Lisenid
4 employees on LinkedIn · 1 known investors
Find your way into Lisenid
394 people in our graph share verified history with the Lisenid team — schools, employers, funds. One of them is your warm intro.
Jon Brosciousunlockedknows Hannah Zhou · together at Advisory (overlapped)
×5knows the team · via Lancaster University
×5knows the team · via Georgetown University McDonough School of Business
knows the team · via Advisory
LisenID develops a molecular diagnostics test and platform that uses Loss of Imprinting (LOI) epigenetic biomarkers combined with AI to detect and predict cancer from routine tumor biopsy samples across multiple cancer types. It targets clinicians and patients facing ambiguous biopsy results, working in the cancer diagnostics field.
Founders & leadership
DN
Dr. Ning ZhouCo-Founder and Chairman
DT
Dr. Tina ChengCo-Founder and CTO
HZ
Hannah ZhouinPartner & CEOHannah Zhou has nearly a decade of experience in health systems, consulting, SaaS, and early-stage biotech, including roles in organizational strategy, product development, and sales. She is Partner and CEO of LisenID, which develops molecular diagnostics tests using epigenetic biomarkers and AI to detect cancer from biopsy samples.
Investors · 1
Competitors · 2
by search overlap
Function Health3 shared keywordsFunction Health provides routine whole-body lab testing, advanced imaging, and access to top doctors to help individuals achieve preventive health awareness and disease avoidance. The company combines medical diagnostics with technology to give patients comprehensive health insights.
Cepheid3 shared keywordsCepheid manufactures molecular diagnostic instruments and tests that automate PCR-based testing for infectious diseases, oncology, and human genetics. The company serves institutions ranging from central laboratories to near-patient settings with automated diagnostic solutions.
Companies competing with Lisenid for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Lisenid do?
- LisenID develops a molecular diagnostics test and platform that uses Loss of Imprinting (LOI) epigenetic biomarkers combined with AI to detect and predict cancer from routine tumor biopsy samples across multiple cancer types. It targets clinicians and patients facing ambiguous biopsy results, working in the cancer diagnostics field.
- Who founded Lisenid?
- Lisenid was founded by Dr. Ning Zhou, Dr. Tina Cheng.
- Who are Lisenid's investors?
- Lisenid's investors include The Innovation Space.